Prospective observational study for appropriateness of blood and blood components therapy in children up to 16 years of age admitted in a tertiary care hospital


  • Vinayaka P. Hegade Department of Paediatrics, Jehangir Hospital, Pune, Maharashtra, India
  • Anjana H. Rao Department of Paediatrics, Shimoga Institute of Medical Sciences, Karnataka, India



Appropriateness, Audit, Blood components, Transfusion


Background: Blood component therapy is a rational replacement therapy of proven clinical value and efficacy, but it is a double-edged sword as it is associated with many hazards of transfusion reaction. Because of ease of availability and gap in the knowledge of medical professional’s blood products are being used very liberally leading to huge mismatch in the demand and supply of life saving blood product.

Methods: Prospective cross-sectional observational study was done over a period of 1 year in a tertiary hospital, in western part of India. 225 events of blood component therapy were studied in neonates (<1month) and pediatric (1month-16years) age groups. Indications and reactions to blood components therapy were studied in both the groups. Each component therapy was considered as one event and its indication was compared with standard guidelines for terming it as appropriate or inappropriate.

Results: Out of total 225 events of transfusions, most commonly used was PRBC (48.9%) followed by FFP (24.9%), platelet (16.0%), IVIG (9.8%) and whole blood (0.4%).  Authors found that overall 17.3% of the component therapy  were inappropriate( neonates 10.2%  and 7.1% in the rest). Most commonly misused blood product was FFP (37.5%) followed by IVIG (22.7%), platelets (16.7%) and PRBC (6.4%).

Conclusions: Regular audit of blood and its component usage is essential to assess the blood utilization pattern and set ideal policies in all the medical specialties to make it appropriate, ensure availability and save patients from its hazards.


McClelland DBL, ed. Handbook of transfusion medicine. United Kingdom blood services 4th edition. TSO publishers London; 2007:5-22.

Madjdpour C, Heindl V, Spahm DR. Risks, benefits, alternatives and indications of allogenic blood transfusion. Minerva Anestesiol. 2006;72(5):283-98.

World Health Organization. The clinical use of blood in obstetrics, pediatrics, surgery and anesthesia, Trauma and Burns; 2001.

World Health Organization. blood transfusion safety: safe and appropriate use; 2002.

British Committee for Standards in Haematology: Transfusion guidelines for neonates and older children. Br J Haematol. 2004;124:433-53.

American Association of Blood Banks (AABB). Bethesda. USA; Technical Manual, 14th ed. 2002.

Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allerg Clinic Immunol. 2006;117(4):S525-53.

Parker RI. Transfusion in critically Ill children: indications, risks, and challenges. Crit Care Med. 2014;42:675-90.

Ching WJ, Tan MK, Kuperan P. An audit of fresh frozen plasma usage in an acute general hospital in Singapore. Singapore Med J. 2003;44(11):574-8.

Bahadur S, Sethi N, Pahuja S, Pathak C, Jain M. Audit of pediatric transfusion practices in a tertiary care hospital. Indian J Pediatr. 2015;82(4):333-9.

Alcantara JC, Opiña AP, Alcantara RA. Appropriateness of use of blood products in tertiary hospitals. IBRR. 2015;3(2):54-65.

Jindal G, Gupta VK. Appropriateness of blood component transfusion in children in a tertiary care teaching hospital. Pediatric Onc. 2015;12(3):370-6.

Martí-Carvajal AJ, Munoz-Navarro SR, Pena-Marti GE, Comunian GA. An audit of appropriate use of blood products in adult patients in a Venezuelan general university hospital. Int J Qual Heal Care. 1999;11(5):391-5.

Ayede AI, Akingbola TS. Pattern, indications and review of complications of neonatal blood transfusion in Ibadan, southwest Nigeria. Annals Ibadan Postgrad Med. 2011;9(1):30-6.

Pedrosa AK, Pinto FJ, Lins LD, Deus GM. Blood transfusion reactions in children: associated factors. J Pediatr. 2013;89(4):400-6.

de Vetten L, Kneyber MCJ, Tamminga RYJ. A restrictive transfusion policy in the paediatric intensive care unit: safe and effective. Neth J Crit Care. 2013;17(3):8-14.

Wade M, Sharma R, Manglani M. Rational use of blood components-an audit. Indian J Hematol Blood Transfus. 2009;25(2):66-9.

Makroo R, Mani R, Vimarsh R, Kansal S, Pushkar K, Tyagi S. Use of blood components in critically ill patients in the medical intensive care unit of a tertiary care hospital. Asian J Transfus Sci. 2009;3(2):82.

Hume H, Ali A, Decary F, Blajchman M. Evaluation of pediatric transfusion practice using criteria maps. Transfusion (Paris). 1991;31(1):52-8.

Mozes B, Epstein M, Ben-Bassat I, Modan B, Halkin H. Evaluation of the appropriateness of blood and blood product transfusion using preset criteria. Transfusion. 1989;29:473-6.

Kakkar N, Kaur R, Dhanoa J. Improvement in fresh frozen plasma /transfusion transfusion practice: results of an outcome audit. Transfus Med, 2004;14:231-5.






Original Research Articles